GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program – Pharmaceutical Technology Magazine
|
GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program
Pharmaceutical Technology Magazine 3, 2018, GeoVax Labs, a clinical-stage biotechnology company specializing in the development of human vaccines, announced a collaboration with Vaxeal, a company focused on developing therapeutic vaccines in combination with immuno-modulatory drugs, for … |
